(Q52018331)
Statements
Prediction of the benefits from dose-escalated hypofractionated intensity-modulated radiotherapy for prostate cancer. (English)
1 reference
Ali M Amer
1 reference
Judith Mott
1 reference
Peter C Williams
1 reference
Jacqueline Livsey
1 reference
John P Logue
1 reference
Jolyon H Hendry
1 reference
1 May 2003
1 reference
56
1 reference
1
1 reference
199-207
1 reference